Bloomage BioTechnology (SHSE:688363) Other Net Income (Loss) : ¥-0 Mil (TTM As of Mar. 2025)

View and export this data going back to 2019. Start your Free Trial

What is Bloomage BioTechnology Other Net Income (Loss)?

Bloomage BioTechnology's Other Net Income (Loss) for the three months ended in Mar. 2025 was ¥0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2025 was ¥-0 Mil.

Bloomage BioTechnology's quarterly Other Net Income (Loss) increased from Sep. 2024 (¥-0 Mil) to Dec. 2024 (¥0 Mil) but then stayed the same from Dec. 2024 (¥0 Mil) to Mar. 2025 (¥0 Mil).

Bloomage BioTechnology's annual Other Net Income (Loss) declined from Dec. 2022 (¥0 Mil) to Dec. 2023 (¥0 Mil) and declined from Dec. 2023 (¥0 Mil) to Dec. 2024 (¥0 Mil).

Bloomage BioTechnology Other Net Income (Loss) Historical Data

The historical data trend for Bloomage BioTechnology's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bloomage BioTechnology Other Net Income (Loss) Chart

Bloomage BioTechnology Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Net Income (Loss)

Get a 7-Day Free Trial

Bloomage BioTechnology Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Net Income (Loss)	Get a 7-Day Free Trial															-	-	-	-	-

Bloomage BioTechnology Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-0 Mil.

Bloomage BioTechnology Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Bloomage BioTechnology's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Bloomage BioTechnology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Bloomage BioTechnology Corp Ltd (SHSE:688363) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 678 Tianchen Avenue, High-Tech Development Zone, Shandong Province, Jinan City, CHN

Website

http://www.bloomagebio-tech.com

Bloomage BioTechnology Corp Ltd manufactures and sells a variety of chemicals and chemical-based products, typically made from hyaluronic acid sodium, or HA. The firm organizes itself into two segments based on product type. The HA raw materials segment, which generates the majority of revenue, sells HA and HA derivatives produced using bio-fermentation technology. The HA raw materials segment products are classified into three grades of HA: medicine grade, cosmetic grade, and food grade. The HA end products segment sells medical skin care products, bone products for intra-articular injection, and medical beauty devices. The majority of revenue comes from China.

Executives

Zhao Yi	Core technical personnel
Luan Yi Hong	Core technical personnel
Shi Yan Li	Core technical personnel
Liu Jian Jian	Core technical personnel
Wang Yu Ling	Core technical personnel
Zhou Wei	Core technical personnel
Huang Si Ling	Core technical personnel
Han Hong Ling	Core technical personnel
Lu Zhen	Core technical personnel

Bloomage BioTechnology Headlines

No Headlines